Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 122

Sort by

Sort Order Select

Journal Articles

Building a National CML Registry

Ehab L. Atallah, MD, Arun K Singavi, MD, Bradley Taylor, Arielle Baim, Judith Myers, Emily Giever, Joan Neuner, MD, Bronwen E. Shaw, MD PhD, Kathryn E Flynn, PhD

Blood (2019) 134 (Supplement_1): 3440.

https://doi.org/10.1182/blood-2019-130358

Published: 2019

Journal Articles

Impact of Competing Treatment Scenarios on Lifetime Disease Burden and Quality Adjusted Life Expectancy (QALE) Among Survivors of High-Risk Childhood Hodgkin Lymphoma (HR-HL): A Modeling Study Based on the St. Jude Lifetime (SJLIFE) Cohort

Nickhill Bhakta, Kalatu Davies, PhD, Jesse Turner, PhD, Yichen Chen, PhD, Jaime Flerlage, MD MS, I-Chan Huang, PhD, Melissa M. Hudson, MD, John T. Lucas, Jr., MD MS, Monika Metzger, MD, Leslie L. Robison, PhD, F. Lennie Wong, PhD

Blood (2019) 134 (Supplement_1): 267.

https://doi.org/10.1182/blood-2019-124907

Published: 2019

Journal Articles

Targeted Therapy of Acute Chest Syndrome with Recombinant Heme Oxygenase-1 Revealed By the Resistance of Young Transgenic Sickle Cell Mice to Heme-Induced Acute Lung Injury

Rimi Hazra, Samit Ghosh, Bethany Flage, Matthew Crouthamel, Clark Pan, Xiuxia Sun, Bohong Zhang, Joseph Sypek, Solomon Fiifi Ofori-Acquah

Blood (2019) 134 (Supplement_1): 74.

https://doi.org/10.1182/blood-2019-127198

Published: 2019

Journal Articles

Updated Results from the Phase II Study of Hyper-CVAD in Sequential Combination with Blinatumomab in Newly Diagnosed Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Guillaume Richard-Carpentier, MD, Hagop M. Kantarjian, MD, Nicholas J. Short, MD, Farhad Ravandi, MD, Alessandra Ferrajoli, MD, Heather M Schroeder, Guillermo Garcia-Manero, MD, Guillermo Montalban Bravo, MD, Jorge E. Cortes, MD, Monica Kwari, BSN, Christopher Loiselle, BS, Rebecca Garris, MSc, Nicole Volter, RDC, Nitin Jain, MD, Marina Y Konopleva, MD PhD, Koichi Takahashi, MD, Koji Sasaki, MD, William G. Wierda, MD PhD, Elias Jabbour, MD

Blood (2019) 134 (Supplement_1): 3807.

https://doi.org/10.1182/blood-2019-129657

Published: 2019

Journal Articles

APC ameliorates pulmonary complications in cGVHD

Vahid Afshar-Kharghan

Blood (2019) 134 (9): 724–725.

https://doi.org/10.1182/blood.2019002182

Published: 2019

Journal Articles

Defining Sickle Cell Disease Severity Among Adults Hospitalized with Vaso-Occlusive Crisis

Kimberly S Esham, MD, Angie Mae Rodday, PhD, Nicole Savidge, BA, Daqin Mao, PhD, Ruth Ann Weidner, MBA, MRP, Susan K Parsons, MD MRP

Blood (2018) 132 (Supplement 1): 3577.

https://doi.org/10.1182/blood-2018-99-111717

Published: 2018

Journal Articles

Quality of Care Indicators in Patients with Sickle Cell Disease (SCD): Influenza Vaccination and Routine Eye Examination Are Associated with Outpatient Utilization but Not Acute Hospital Care, Whereas Comorbidity Indexes Are Strongly Associated with Both

Tom Adamkiewicz, MD FRCPC, MSc, Peter Baltrus, PhD, Chaohua Li, MPH, Kitty Carter-Wicker, MD, Anne Gaglioti, MD

Blood (2018) 132 (Supplement 1): 3574.

https://doi.org/10.1182/blood-2018-99-120132

Published: 2018

Journal Articles

Safety and Efficacy of Non-Irradiated Granulocyte Transfusions (GTX) in Neutropenic Patients with Severe or Refractory Abdominal Infections: A Single Center Retrospective Analysis of 119 Transfusions in 22 Patients

Guillaume Richard-Carpentier, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Tapan M. Kadia, MD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, Courtney D. DiNardo, MD MSc, William G. Wierda, MD PhD, Naval G. Daver, MD, Naveen Pemmaraju, MD, Prithviraj Bose, MD, Marina Y. Konopleva, MD PhD, Michael Andreeff, MD PhD, Srdan Verstovsek, MD PhD, Heidi M Krause, Fleur M. Aung, MD, Jorge E. Cortes, MD

Blood (2018) 132 (Supplement 1): 3815.

https://doi.org/10.1182/blood-2018-99-119702

Published: 2018

Journal Articles

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD MPH, Anja C. Roden, MD, Mrinal M. Patnaik, MD MBBS, Reona Sakemura, MD PhD, Nandita Khera, MD, Vivek Roy, MD, Cassie C. Kennedy, MD, William J. Hogan, MB, BCh, Mark R. Litzow, MD, Hemang Yadav, MBBS

Blood (2018) 132 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2018-99-118930

Published: 2018

Journal Articles

Impact of Pretransplant HTLV-1 Seropositivity on Hematopoietic Stem Cell Transplantation for the Diseases Other Than ATLL- an Analysis on Behalf of JSHCT Complication Working Group-

Nobuaki Nakano, MD, Hideki Nakasone, MD PhD, Shigeo Fuji, MD PhD, Akihito Shinohara, MD PhD, Ritsuro Suzuki, MD PhD, Atae Utsunomiya, MD PhD, Tetsuya Eto, MD PhD, Yasushi Sawayama, MD, PhD, Sawako Nakachi, MD PhD, Naoyuki Uchida, MD PhD, Takahiro Fukuda, MD PhD, Junya Kanda, MD, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD

Blood (2018) 132 (Supplement 1): 4641.

https://doi.org/10.1182/blood-2018-99-114111

Published: 2018

Journal Articles

Incidence of Breakthrough Invasive Fungal Infections after Posaconazole Prophylaxis in Allogeneic Stem Cell Transplant Patients

Rayaz Ahmed, MD DM, Sanghmitra Thakur, MSc, Jyotsna Kapoor, MSc, Narendra Agrawal, MD DM, Pallavi Mehta, MD DM, Shinto Francis Thekuddan, MD DM, Ambar Garg, MD, Dinesh Bhurani, MD DM, FRCPA

Blood (2018) 132 (Supplement 1): 5695.

https://doi.org/10.1182/blood-2018-99-118157

Published: 2018

Journal Articles

Reduced Dose of Post-Transplant Cyclophosphamide for HLA Haploidentical Peripheral Blood Stem Cell Transplantation

Satoshi Morishige, MD, Yoshitaka Yamasaki, MD, Shuki Oya, MD, Takayuki Nakamura, MD, Maki Ymaguchi, MD PhD, Kazutoshi Aoyama, MD PhD, Ritsuko Seki, PhD, Fumihiko Mouri, MD PhD, Koichi Osaki, MD, Koji Nagafuji, MD PhD

Blood (2018) 132 (Supplement 1): 5698.

https://doi.org/10.1182/blood-2018-99-112436

Published: 2018

Journal Articles

Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)

Carmen Martinez, MD PhD, Cecilia Carpio, MD, Inmaculada Heras, Eduardo Ríos Herranz, MD, Joan Buch, Antonio Gutierrez, MD PhD, Samuel Romero, Izaskun Ceberio, Irene Garcia-Garcia, Antonia Rodriguez Izquierdo, PhD, Rosalia Alonso, Joan Bargay, MD PhD, Cristina Barrenetxea Lekue, PhD, Narvaez Javier, Manuel Espeso de Haro, MD, Luis Palomera, MD PhD, Ramon García-Sanz, MD PhD

Blood (2018) 132 (Supplement 1): 2936.

https://doi.org/10.1182/blood-2018-99-115774

Published: 2018

Journal Articles

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

F. Lennie Wong, PhD, Meisi Xiao, MPH, Jennifer Berano Teh, Liezl Atencio, Alicia Gonzales, Amy Hinton, David Iukuridze, Stephen J Forman, Ryotaro Nakamura, MD, Saro H. Armenian, DO,MPH

Blood (2018) 132 (Supplement 1): 368.

https://doi.org/10.1182/blood-2018-99-112646

Published: 2018

Journal Articles

Long-Term Morbidity Associated with Chronic Graft Vs. Host Disease (cGvHD) - a Blood or Marrow Transplant Survivor Study (BMTSS)

Mukta Arora, MD, Yanjun Chen, Jessica Wu, BA, Lindsey Hageman, MPH, Liton F. Francisco, BS, Emily Ness, MPH, Mariel Parman, MPH, Michelle Kung, MA, Alysia Bosworth, BA, Manju Nayar, Ravi Bhatia, MD, Stephen J. Forman, MD FACP, Daniel J. Weisdorf, MD, Saro H. Armenian, DO,MPH, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 336.

https://doi.org/10.1182/blood.V130.Suppl_1.336.336

Published: 2017

Journal Articles

In Children with Sickle Cell Anemia, Low Baseline BMI Is Associated with a Longitudinal Decline in FEV 1 % Predicted

Jodi-Anne T Stewart, BS, Mark Rodeghier, PhD, Michael R. DeBaun, MD MPH, Shaina M Willen, MD

Blood (2017) 130 (Supplement 1): 618.

https://doi.org/10.1182/blood.V130.Suppl_1.618.618

Published: 2017

Journal Articles

Arteriolar Bottle-Necks in the Lung Are the Site of Pulmonary Thrombo-Embolism

Tomasz Brzoska, PhD, Ravi Vats, MSc, Egemen Tutuncuoglu, MSc, Margaret F. Bennewitz, PhD, Maritza Ann Jimenez, BS, Matthew D Neal, MD, Prithu Sundd, PhD

Blood (2017) 130 (Supplement 1): 1093.

https://doi.org/10.1182/blood.V130.Suppl_1.1093.1093

Published: 2017

Journal Articles

Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia

Lane Miller, MD, Sharon M. Castellino, MD MSc, Ann Mertens, PhD, Frank G Keller, MD, William G Woods, MD

Blood (2017) 130 (Supplement 1): 2590.

https://doi.org/10.1182/blood.V130.Suppl_1.2590.2590

Published: 2017

Journal Articles

Pulmonary Hypertension and Associated Risk Factors in a High Burden Sickle Cell Disease Population

Jane Sandra Afriyie-Mensah, Yvonne Adomakoh, MBBS, Audrey Forson, MBChB, Adadey Martin, MBChB, Joseph Acquaye, MBBS

Blood (2017) 130 (Supplement 1): 2261.

https://doi.org/10.1182/blood.V130.Suppl_1.2261.2261

Published: 2017

Journal Articles

Tissue-Resident TSP1-CD47 Signaling Promotes Sickle Cell-Associated Arterial Vasculopathy and Pulmonary Hypertension

Enrico M Novelli, MD MS, Lynda L Ihrig, Heather E Knupp, MSc, Natasha M Rogers, Mingyi Yao, PhD, Xiaojun Huang, Jeffrey Baust, Daniel Meijles, PhD, Claudette M St Croix, PhD, Mark A Ross, Patrick J Pagano, PhD, Hunter C Champion, MD PhD, George Miles, MD PhD, Karin P Potoka, MD, Mark T Gladwin, MD, Jeffrey S Isenberg

Blood (2017) 130 (Supplement 1): 957.

https://doi.org/10.1182/blood.V130.Suppl_1.957.957

Published: 2017

NARROW

Building a National CML Registry

Impact of Competing Treatment Scenarios on Lifetime Disease Burden and Quality Adjusted Life Expectancy (QALE) Among Survivors of High-Risk Childhood Hodgkin Lymphoma (HR-HL): A Modeling Study Based on the St. Jude Lifetime (SJLIFE) Cohort

Targeted Therapy of Acute Chest Syndrome with Recombinant Heme Oxygenase-1 Revealed By the Resistance of Young Transgenic Sickle Cell Mice to Heme-Induced Acute Lung Injury

Updated Results from the Phase II Study of Hyper-CVAD in Sequential Combination with Blinatumomab in Newly Diagnosed Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)

APC ameliorates pulmonary complications in cGVHD

Defining Sickle Cell Disease Severity Among Adults Hospitalized with Vaso-Occlusive Crisis

Quality of Care Indicators in Patients with Sickle Cell Disease (SCD): Influenza Vaccination and Routine Eye Examination Are Associated with Outpatient Utilization but Not Acute Hospital Care, Whereas Comorbidity Indexes Are Strongly Associated with Both

Safety and Efficacy of Non-Irradiated Granulocyte Transfusions (GTX) in Neutropenic Patients with Severe or Refractory Abdominal Infections: A Single Center Retrospective Analysis of 119 Transfusions in 22 Patients

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Impact of Pretransplant HTLV-1 Seropositivity on Hematopoietic Stem Cell Transplantation for the Diseases Other Than ATLL- an Analysis on Behalf of JSHCT Complication Working Group-

Incidence of Breakthrough Invasive Fungal Infections after Posaconazole Prophylaxis in Allogeneic Stem Cell Transplant Patients

Reduced Dose of Post-Transplant Cyclophosphamide for HLA Haploidentical Peripheral Blood Stem Cell Transplantation

Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)

Conditional Survival and Mortality Risks after Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Patients Who Survived Varying Length of Time after Allohct

Long-Term Morbidity Associated with Chronic Graft Vs. Host Disease (cGvHD) - a Blood or Marrow Transplant Survivor Study (BMTSS)

In Children with Sickle Cell Anemia, Low Baseline BMI Is Associated with a Longitudinal Decline in FEV 1 % Predicted

Arteriolar Bottle-Necks in the Lung Are the Site of Pulmonary Thrombo-Embolism

Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia

Pulmonary Hypertension and Associated Risk Factors in a High Burden Sickle Cell Disease Population

Tissue-Resident TSP1-CD47 Signaling Promotes Sickle Cell-Associated Arterial Vasculopathy and Pulmonary Hypertension

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only